VoxNeuro Inc., a Boston, MA-based company that develops EEG-based brain performance software, closed its second financing round with nearly USD $3.4m raised.
The round was led by the company’s largest shareholder, in addition to its strategic investor g.tec, a brain-computer interface and neurotechnology company that serves as VoxNeuro’s strategic supplier of EEG hardware.
The company intends to use the funds to execute commercial expansion plans to scale clinical installations across the US.
Led by Jason Flowerday, Chief Executive Officer, VoxNeuro develops EEG-based brain performance software to objectively assess cognitive function. Its first in-clinic product, VoxNeuro CORE, leverages event-related potentials (ERPs) to provide clinicians with easy-to-interpret reports on their patients’ cognitive function.
Further in its pipeline, VoxNeuro is developing a machine-learning (ML) enhancement to its current clinical tool. The new machine learning algorithm boasts advanced features that promote increased precision, specificity and a more holistic view of patients’ cognitive health.
FinSMEs
03/08/2023